Beverly Hills Private Wealth, LLC

Position in ABBV — AbbVie Inc.

CIK 1965710 BEVERLY HILLS, CA

Position in ABBV

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$1,551,108

-$1,161,861 QoQ

Shares Held

6,164

-50.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.37%

of 13F equity value

Holder Rank

#2,149

of 4,153 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Beverly Hills Private Wealth, LLC holds $13,330,659 across 9 Drug Manufacturers - General names. ABBV ranks #4 (11.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	14,225	$3,612,722
2	NVO	Novo Nordisk A S	63,562	$3,047,161
3	GSK	GSK plc	33,201	$1,740,395
4	ABBV	AbbVie Inc. This page	6,164	$1,551,108
5	LLY	ELI LILLY & Co	994	$1,192,233
6	AMGN	Amgen Inc	2,339	$846,998
7	MRK	Merck & Co., Inc.	5,600	$719,600
8	NVS	Novartis AG	2,596	$406,845

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,551,108	6,164	-50.6%	Shares	Sole	2026-08-07
2026-03-31	$2,712,969	12,474	-4.5%	Shares	Sole	2026-05-04
2025-12-31	$2,985,678	13,067	-2.5%	Shares	Sole	2026-02-17
2025-09-30	$3,101,938	13,397	-2.8%	Shares	Sole	2025-11-10
2025-06-30	$2,558,026	13,781	+0.5%	Shares	Sole	2025-07-29
2025-03-31	$2,873,774	13,716	-6.9%	Shares	Defined	2025-04-30
2024-12-31	$2,617,874	14,732	+2.0%	Shares	Sole	2025-02-14
2024-09-30	$2,852,002	14,442	-9.4%	Shares	Defined	2024-11-12
2024-06-30	$2,735,569	15,949	-5.8%	Shares	Sole	2024-08-08
2024-03-31	$3,083,861	16,935	-7.0%	Shares	Defined	2024-05-09
2023-12-31	$2,821,690	18,208	-1.8%	Shares	Sole	2024-01-30
2023-09-30	$2,763,421	18,539	-46.9%	Shares	Sole	2023-11-08
2023-06-30	$4,705,445	34,925	+94.3%	Shares	Sole	2023-08-10
2023-03-31	$2,864,994	17,977	+19.3%	Shares	Sole	2023-05-04
2022-12-31	$2,434,816	15,066	—	Shares	Sole	2023-02-13
No filing history on record for this holder in this stock.